ScholarMate
English简体中文繁體中文
客服热线:400-1616-289
登录注册
期刊论文

Invasive Pulmonary Aspergillosis in Acute-on-Chronic Liver Failure Patients: Short-Term Outcomes and Antifungal Options

Chen, Danli; Qian, Zhiping; Su, Haibin; Meng, Zhongji; Lv, Jun; Huang, Yan; Gao, Yanhang; Liu, Jingyuan; Zhao, Caiyan; Gao, Hongbo; Chen, Yu; Xia, Jie; Peng, Liang; Han, Tao; Li, Hai; Zheng, Xin; Wang, Xianbo*; Lu, Xiaobo; Shi, Yu*; Hu, Jinhua; Chen, Jinjun*复旦大学; 广州医学院; 华中科技大学; 吉林大学; 南方医科大学; 上海交通大学; 河北医科大学; 浙江大学; 郑州大学; 中山大学; 1; 5; y
Infectious Diseases and Therapy2021-12DOI: 10.1007/s40121-021-00524-5
3被引15阅读
引用收藏
分享

摘要

Introduction Acute-on-chronic liver failure (ACLF) patients are susceptible to invasive fungal infections. We evaluated the prognosis and antifungal options in ACLF patients with invasive pulmonary aspergillosis (IPA). Methods ACLF patients with IPA from 15 hospitals were retrospectively screened from 2011 to 2018, and 383 ACLF patients without lung infections were included from a prospective cohort (NCT02457637). Demographic, laboratory, clinical data, and 28-day outcomes were documented in the two cohorts. Results ACLF patients with probable IPA (n = 145) had greater 28-day mortality (33.6% vs. 15.7%, p < 0.001) than those without (n = 383). The respiratory failure-associated 28-day mortality was greater in ACLF patients with IPA than in those without before (17.1% vs. 0.3%, p < 0.001) and after (16.0% vs. 0.0%, p < 0.001) propensity score matching in 116 pairs. IPA patients with lung injury had greater 28-day all-cause mortality (66.5% vs. 24.2%, p < 0.001) and IPA-associated mortality (45.8% vs. 8.1%, p < 0.001) than patients without lung injury (PaO2/FiO2 >= 400 mmHg). Antifungal therapy was prescribed to 139 of 145 patients, and 102 patients were treated with voriconazole alone (n = 59) or sequential/combined therapy (n = 43) with varying loading doses (100-800 mg) and daily maintenance doses (0-800 mg). A proposed optimal voriconazole regimen (loading dose, 200 mg twice daily; daily maintenance dose, 100 mg) achieved comparable short-term survival and optimal trough drug concentrations (1-5 mu g/mL) on therapeutic drug monitoring in 26 patients. Conclusion Presence of IPA increases the short-term mortality of ACLF patients mainly due to respiratory failure. An optimal voriconazole regimen is needed for such critical patients.

学科与关键词

关键词
Acute-on-chronic liver failureInvasive pulmonary aspergillosisLung injuryOrgan failurePrognosisPropensity score matchingRespiratory failureVoriconazoleTherapeutic drug monitoring
相关
加载中…
  • Spontaneous Fungal Ascites Infection in Patients with Cirrhosis: An Analysis of 10 Cases
    Li, Beiling; Yang, Chao; Qian, Zhiping; Huang, Yan; Wang, Xianbo; Zhong, Guotao; Chen, Jinjun*Infectious Diseases and Therapy, 2021, 10(2): 1033-1043.被引 4
  • Voriconazole therapeutic drug monitoring and hepatotoxicity in critically ill patients: A nationwide multi-centre retrospective study
    Wang, Taotao; Miao, Liyan; Shao, Hua; Wei, Xiaohua; Yan, Miao; Zuo, Xiaocong; Zhang, Jun; Hai, Xin; Fan, Guangjun; Wang, Wei; Hu, Linlin; Zhou, Jian; Zhao, Yichang; Xie, Yueliang; Wang, Jingjing; Guo, Sixun; Jin, Liu; Li, Hao; Liu, Hui; Wang, Quanfang; Chen, Jiaojiao; Li, Sihan; Dong, Yalin*International Journal of Antimicrobial Agents, 2022, 60(5-6): 106692.被引 5
  • New Algorithm Rules Out Acute-on-chronic Liver Failure Development within 28 Days from Acute Decompensation of Cirrhosis
    Tang, Xiaoting; Li, Hai; Deng, Guohong; Zheng, Xin; Wang, Xianbo; Huang, Yan; Gao, Yanhang; Meng, Zhongji; Qian, Zhiping; Liu, Feng; Lu, Xiaobo; Shi, Yu; Li, Beiling; Gu, Wenyi; Xiang, Xiaomei; Xiong, Yan; Hou, Yixin; Chen, Jun; Gao, Na; Luo, Sen; Ji, Liujuan; Li, Jing; Zheng, Rongjiong; Ren, Haotang; Chen, JinjunJournal of Clinical and Translational Hepatology, 2023, 11(3): 550-559.
查看全部 →

发表信息

论文状态
公开发表
期刊
Infectious Diseases and Therapy
发表日期
2021-12
卷期
第 10 卷, 第 4 期
页码
2525-2538
DOI
10.1007/s40121-021-00524-5
期刊收录
NSL
期刊等级
3区
成果收录
SCIE
资助标注
National Science and Technology Major Project [2018ZX10723203, 2018ZX10302206, 2017ZX10302201-004-007]; National Natural Science Foundation of China [82070650, 81270533, 81470038, 81902470]; National Key Research and Development Program of China [2017YFC0909104]; Local Innovative and Research Teams Project of Guangdong Pearl River Talents Program [2017BT01S131]; Key Scientific and Technological Program of Guangzhou City [201508020262]; Department of Science and Technology of Guangdong Province [2014B020228003, 2015B020226004]; Clinical Research Program of Nanfang Hospital, Southern Medical University [2018CR037]; Southern Medical University by High-level University Construction Funding of Guangdong Provincial Department of Education [LC2019ZD006, LC2016PY005]; President Foundation of Nanfang Hospital, Southern Medical University [2019Z003]

作者

  • C

    Chen, Danli (第一作者)

    southern med univ

  • Q

    Qian, Zhiping

    fudan univ

查看全部 21 位作者收起作者
  • S

    Su, Haibin

    5 · peoples liberat army gen hosp

  • M

    Meng, Zhongji

    hubei univ med

  • L

    Lv, Jun

    1 · zhengzhou univ

  • H

    Huang, Yan

  • G

    Gao, Yanhang

    jilin univ

  • L

    Liu, Jingyuan

    beijing ditan hosp · capital med univ

  • Z

    Zhao, Caiyan

    hebei med univ

  • G

    Gao, Hongbo

    guangzhou med univ

  • C

    Chen, Yu

    capital med univ

  • X

    Xia, Jie

  • P

    Peng, Liang

    sun yat sen univ

  • H

    Han, Tao

    tianjin third cent hosp

  • L

    Li, Hai

    shanghai jiao tong univ

  • Z

    Zheng, Xin

    huazhong univ sci & technol

  • W

    Wang, Xianbo (通讯)

    beijing ditan hosp · capital med univ

  • L

    Lu, Xiaobo

    1 · xinjiang med univ

  • S

    Shi, Yu (通讯)

    1 · zhejiang univ

  • H

    Hu, Jinhua

    5 · peoples liberat army gen hosp

  • C

    Chen, Jinjun (通讯)

    southern med univ

登录解锁更多功能

  • 收藏这篇,随时在“我的 · 收藏”找回
  • 认领你的成果,生成推广素材
  • 关注作者获取最新成果
  • 加入项目组、协同写作
注册 / 登录

产品服务

  • 科研之友
  • 创新城
  • 科创云

服务支持

  • 帮助中心
  • 隐私政策
  • 服务条款

联系方式

在线客服:【】
客服热线:400-1616-289
电子邮箱:support@scholarmate.com

关注或下载科研之友

微信二维码
微信公众号
客户端下载二维码
下载客户端
科研成果科研人员科研机构科研动态爱瑞思软件

©2026 深圳市科研之友网络服务有限公司

公安备案图标粤公网安备 44030502000213
粤ICP备 16046710 号粤B2-20110417